Product
Rebif
2 clinical trials
1 indication
Indication
Multiple SclerosisClinical trial
INFORM - Interferon-Beta Exposure in the 2nd and 3rd Trimester of Pregnancy - a Register-Based Drug Utilisation Study in Finland and SwedenStatus: Not yet recruiting, Estimated PCD: 2026-03-31
Clinical trial
International, Multicenter, Double-blinded, Placebo-controlled, Randomized Study of the Efficacy and Safety of Drugs BCD-033 and Rebif for the Treatment of Patients With Relapsing-remitting Multiple SclerosisStatus: Completed, Estimated PCD: 2016-11-21